COMBIVIR

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug COMBIVIR contains a combination of these active pharmaceutical ingredients (APIs):

1 Lamivudine UNII 2T8Q726O95 - LAMIVUDINE

Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription. Read about Lamivudine

2 Zidovudine UNII 4B9XT59T7S - ZIDOVUDINE

Zidovudine is an antiviral agent which is highly active in vitro against retroviruses including the Human Immunodeficiency Virus (HIV). Read about Zidovudine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
COMBIVIR Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AR01	Zidovudine and lamivudine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AR Antivirals for treatment of HIV infections, combinations
Discover more medicines within J05AR01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10284G
Country: CA	Health Products and Food Branch	Identifier(s): 02239213
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00494433, 00499241, 00728954, 00789074, 00800947, 00970069, 02654970, 08725085, 10227880, 11710696
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2946-MEE-0817
Country: EE	Ravimiamet	Identifier(s): 1036460
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 98058001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 101916
Country: FR	Base de données publique des médicaments	Identifier(s): 65521773
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 40280
Country: HK	Department of Health Drug Office	Identifier(s): 63605
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250100F1032
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1012168, 1028280, 1055421
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 095M98
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50059
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100088859
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65649001, W65649002
Country: SG	Health Sciences Authority	Identifier(s): 10795P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 23013031
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522096053
Country: US	FDA, National Drug Code	Identifier(s): 49702-202
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/20.2.8/0705